Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
16/12 update: Buy with the stop loss at $1.83
27/11 update: Wait for buying interest to pick up and the first test-first-fail pattern to form.
Washington H. Soul Pattinson and Company is under Algo Engine buy conditions.
Zscaler, Inc. – Common: Buy on a price move above the 10-day average.
First quarter 2026 earnings: EPS and revenues exceed analyst expectations
First quarter 2026 results:
Revenue exceeded analyst estimates by 1.8%. Earnings per share (EPS) also surpassed analyst estimates by 37%.
Revenue is forecast to grow 16% p.a. on average during the next 3 years.
Ramsay Health Care: first quarter revenue up 6.5 per cent and EBIT up 5.8 per cent.
Buy on a move above the 10-day average.
Betashares S&P/ASX Australian Technology
Add to the watchlist and wait for a close above the 10-day average.
Oracle Corporation is rated a Buy driven by AI and cloud momentum.
ORCL’s cloud revenue surged 28% YoY, fueled by a $300B OpenAI deal.
16/12 update: XRO is trading at $110, and we’re monitoring price action for increased buying interest and a close above the 10-day average.
Xero Add to your watchlist.
1H26: Overall, a weaker result vs market expectations despite EBITDA a slight beat. EBITDA-capex cash flow came in -6% below consensus. Whilst operating costs have seen good control, capex spend is trending up due to investments in new AI capabilities.
Look for buying interest to rebuild, and we’ll revisit the entry point once the price action is above the 10-day average.
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Or start a free thirty day trial for our full service, which includes our ASX Research.
